Vitamin D and neurocognitive function

Article, Review English OPEN
Schlögl, Mathias ; Holick, Michael F (2014)
  • Publisher: Dove Medical Press
  • Journal: Clinical Interventions in Aging, volume 9, pages 559-568 (issn: 1176-9092, eissn: 1178-1998)
  • Related identifiers: doi: 10.2147/CIA.S51785, pmc: PMC3979692
  • Subject: Mild-cognitive impairment | cognition | vitamin D | 25(OH)D level | vascular dementia | Clinical Interventions in Aging | RC952-954.6 | Alzheimer’s disease | Malnutrition | Geriatrics | Review | Mortality | mild cognitive impairment | Aging

Mathias Schlögl,1 Michael F Holick21University Center for Medicine of Aging Basel, University of Basel, Basel, Switzerland; 2Department of Medicine, Section of Endocrinology, Nutrition, and Diabetes, Vitamin D, Skin, and Bone Research Laboratory, Boston University Medical Center, Boston, MA, USAAbstract: In recent years, emerging evidence has linked vitamin D not only to its known effects on calcium and bone metabolism, but also to many chronic illnesses involving neurocognitive decline. The importance of vitamin D3 in reducing the risk of these diseases continues to increase due to the fact that an increasing portion of the population in developed countries has a significant vitamin D deficiency. The older population is at an especially high risk for vitamin D deficiency due to the decreased cutaneous synthesis and dietary intake of vitamin D. Recent studies have confirmed an association between cognitive impairment, dementia, and vitamin D deficiency. There is a need for well-designed randomized trials to assess the benefits of vitamin D and lifestyle interventions in persons with mild cognitive impairment and dementia.Keywords: vitamin D, 25(OH)D level, cognition, mild cognitive impairment, Alzheimer's disease, vascular dementia
  • References (147)
    147 references, page 1 of 15

    1. Holick MF. Vitamin D decfiiency. N Engl J Med. 2007;357(3): 266-281.

    2. Dobs AS, Levine MA, Margolis S. Effects of pravastatin, a new HMGCoA reductase inhibitor, on vitamin D synthesis in man. Metabolism. 1991;40(5):524-528.

    3. Godar DE, Pope SJ, Grant WB, Holick MF. Solar UV doses of adult Americans and vitamin D(3) production. Dermatoendocrinol. 2011;3(4):243-250.

    4. Holick MF. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging. 2007;24(12):1017-1029.

    5. Holick MF. Evolution and function of vitamin D. Recent Results Cancer Res. 2003;164:3-28.

    6. Lehmann B, Tiebel O, Meurer M. Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents - a preliminary study. Arch Dermatol Res. 1999;291(9):507-510.

    7. Bikle DD, Halloran BP, Riviere JE. Production of 1,25 dihydroxyvitamin D3 by perfused pig skin. J Invest Dermatol. 1994;102(5):796-798.

    8. Seifert M, Tilgen W, Reichrath J. Expression of 25-hydroxyvitamin D-1alpha-hydroxylase (1alphaOHase, CYP27B1) splice variants in HaCaT keratinocytes and other skin cells: modulation by culture conditions and UV-B treatment in vitro. Anticancer Res. 2009;29(9): 3659-3667.

    9. Fu GK, Lin D, Zhang MY, et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol. 1997;11(13):1961-1970.

    10. Lehmann B, Genehr T, Knuschke P, Pietzsch J, Meurer M. UVB-induced conversion of 7-dehydrocholesterol to 1alpha, 25-dihydroxyvitamin D3 in an in vitro human skin equivalent model. J Invest Dermatol. 2001;117(5):1179-1185.

  • Related Research Results (1)
  • Metrics
    No metrics available
Share - Bookmark